PGR and cancer: Because TNBC lacks overexpression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) and no effective drugs are currently available, the biology of this complex cancer must be discerned to develop specific therapeutic strategies to improve patient survival [28, 29].